Featured Research

from universities, journals, and other organizations

One molecule opens the door to new treatments for depression

Date:
April 23, 2010
Source:
Ecole Polytechnique Federale de Lausanne (EPFL)
Summary:
There has been little progress in the way we treat depression and anxiety for over thirty years, but a recent study may open the door to new strategies. A new article explains how understanding the functioning of a molecule called MIF, or macrophage migration inhibitory factor, may change the way we treat depression.

MIF molecule - new treatment for depression?
Credit: Pascal Coderay, EPFL

There has been little progress in the way we treat depression and anxiety for over thirty years, but a recent study at EPFL Ecole Polytechnique Fιdιrale de Lausanne (EPFL) may open the door to new strategies. In an article published online in Molecular Psychiatry, researchers from two laboratories at the Brain Mind Institute at EPFL (Ecole Polytechnique Fιdιrale de Lausanne) explain how understanding the functioning of a molecule called MIF, or macrophage migration inhibitory factor, may change the way we treat depression.

Related Articles


Clinical depression affects 121 million people around the world, according to the World Health Organization, but only 60% to 80% of cases are effectively treated with current medication and psychotherapy. "These findings underscore MIF as a potentially relevant molecular target for the development of treatments linked to deficits in neurogenesis, as well as to problems related to anxiety, depression, and cognition," explains Carmen Sandi from the Laboratory of Behavioral Genetics.

MIF is normally thought to play a role in tissue swelling and even cancer development, but its precise location and function in the brain remained a mystery before Sandi's study. Sandi's team first detected a concentration of MIF protein in stem cells in the hippocampus, a key area for memory formation and neuron generation during adulthood. New neurons are thought to be linked to the creation of new memories but they may also play an important role in curbing anxiety -- previous studies have shown that prolonged periods of stress reduce neurogenesis, and many anti-depressants actually boost the production of new neurons.

By genetically and pharmaceutically manipulating the level of MIF in the hippocampus of rats, the researchers discovered that the absence of MIF significantly reduced the production of neurons and increased anxiety They also found that the lack of MIF decreases the ability of anti-depressants to stimulate neurogenesis.

These findings have led the researchers to conclude that MIF plays an important role in neurogenesis and, in turn, the condition of anxiety and depression. Hilal Lashuel's group, from the Laboratory of Molecular Neurobiology and Functional Neuroproteomics at EPFL's Brain Mind Institute, had already been interested in MIF, but this discovery has led the team to explore new possibilities for treatments focusing on the MIF molecule.


Story Source:

The above story is based on materials provided by Ecole Polytechnique Federale de Lausanne (EPFL). Note: Materials may be edited for content and length.


Journal Reference:

  1. L Conboy, E Varea, J E Castro, H Sakouhi-Ouertatani, T Calandra, H a Lashuel and C Sandi. Macrophage migration inhibitory factor (MIF) is critically involved in basal and fluoxetine-stimulated adult hippocampal cell proliferation and in anxiety, depression, and memory-related behaviors. Molecular Psychiatry, 23 February 2010 DOI: 10.1038/mp.2010.15

Cite This Page:

Ecole Polytechnique Federale de Lausanne (EPFL). "One molecule opens the door to new treatments for depression." ScienceDaily. ScienceDaily, 23 April 2010. <www.sciencedaily.com/releases/2010/04/100412084408.htm>.
Ecole Polytechnique Federale de Lausanne (EPFL). (2010, April 23). One molecule opens the door to new treatments for depression. ScienceDaily. Retrieved December 21, 2014 from www.sciencedaily.com/releases/2010/04/100412084408.htm
Ecole Polytechnique Federale de Lausanne (EPFL). "One molecule opens the door to new treatments for depression." ScienceDaily. www.sciencedaily.com/releases/2010/04/100412084408.htm (accessed December 21, 2014).

Share This


More From ScienceDaily



More Mind & Brain News

Sunday, December 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) — In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) — A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com
Prenatal Exposure To Pollution Might Increase Autism Risk

Prenatal Exposure To Pollution Might Increase Autism Risk

Newsy (Dec. 18, 2014) — Harvard researchers found children whose mothers were exposed to high pollution levels in the third trimester were twice as likely to develop autism. Video provided by Newsy
Powered by NewsLook.com
Yoga Could Be As Beneficial For The Heart As Walking, Biking

Yoga Could Be As Beneficial For The Heart As Walking, Biking

Newsy (Dec. 17, 2014) — Yoga can help your weight, blood pressure, cholesterol and heart just as much as biking and walking does, a new study suggests. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins